• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

Introduction to Solasodine Hydrochloride (CAS No: 6106-33-8)

Solasodine Hydrochloride, with the chemical formula C??H??NO?·HCl, is a naturally occurring steroid glycoside derivative primarily extracted from the roots of the Solanum sode plant, which is widely recognized in traditional medicine systems. This compound has garnered significant attention in the field of pharmaceutical chemistry and medicinal research due to its diverse biological activities and potential therapeutic applications. The hydrochloride salt form enhances its solubility and stability, making it more suitable for various pharmacological studies and clinical trials.

The chemical structure of Solasodine Hydrochloride features a steroidal backbone with multiple hydroxyl and glycosidic groups, which contribute to its unique pharmacological properties. Its molecular weight is approximately 549.63 g/mol, and it typically appears as a white to off-white crystalline powder. The compound's solubility in water and organic solvents makes it an ideal candidate for formulation development in drug delivery systems.

In recent years, Solasodine Hydrochloride has been the subject of extensive research due to its demonstrated biological activities. Studies have shown that it exhibits potent anti-inflammatory, antioxidant, and anticancer properties. The anti-inflammatory effects are attributed to its ability to modulate cytokine production and inhibit the activity of key inflammatory enzymes such as COX-2 and NF-κB. Additionally, its antioxidant properties stem from its capacity to scavenge free radicals and enhance the activity of endogenous antioxidant enzymes like superoxide dismutase (SOD) and catalase.

One of the most promising areas of research involving Solasodine Hydrochloride is its potential as an anticancer agent. Preclinical studies have revealed that it can induce apoptosis in various cancer cell lines by activating caspase-dependent pathways and inhibiting the expression of anti-apoptotic proteins such as Bcl-2. Furthermore, its ability to disrupt microtubule formation has been observed in some cancer cell lines, leading to cell cycle arrest and subsequent apoptosis. These findings have prompted further investigation into its efficacy as a monotherapy or adjuvant therapy in oncology.

The pharmacokinetic profile of Solasodine Hydrochloride has also been extensively studied. Following oral administration, it exhibits moderate bioavailability with a peak plasma concentration typically observed within 1-3 hours. The compound undergoes extensive metabolism in the liver via phase I and phase II enzymatic pathways, with glucuronidation being the primary route of excretion. These metabolic pathways ensure that any residual activity is rapidly eliminated from the body, minimizing potential side effects.

Recent advances in synthetic chemistry have enabled the development of more efficient methods for the large-scale production of Solasodine Hydrochloride. These methods include enzymatic glycosylation and chiral resolution techniques, which improve yield and purity while reducing environmental impact. Such innovations are crucial for ensuring that this compound remains accessible for both research purposes and potential clinical applications.

The therapeutic potential of Solasodine Hydrochloride extends beyond oncology into other areas such as neurodegenerative diseases and autoimmune disorders. Preliminary studies suggest that it may protect against neurotoxicity associated with conditions like Alzheimer's disease by inhibiting beta-amyloid aggregation. Similarly, its immunomodulatory effects have been explored in autoimmune diseases such as rheumatoid arthritis, where it shows promise in reducing inflammation and alleviating symptoms.

In conclusion, Solasodine Hydrochloride (CAS No: 6106-33-8) is a multifaceted compound with significant therapeutic potential across multiple disease areas. Its natural origin combined with synthetic advancements makes it a valuable asset in modern pharmaceutical research. As further clinical trials are conducted, the full spectrum of its applications is expected to become clearer, paving the way for novel treatments in medicine.

• 126-17-0(solasodine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)